Polycystic ovary syndrome (PCOS) is one of the most common gynecological endocrine disorders, with sporadic ovulation, excessive androgens, and polycystic ovarian changes as the main clinical manifestations. Due to the high heterogeneity of its clinical manifestations, the discussion on its pathogenesis has not been unified. Current research has found that genetic factors, hyperandrogenism, chronic inflammation and oxidative stress, insulin resistance, and obesity are strongly associated with PCOS. Recently, when studying the specific mechanisms of the abovementioned factors in PCOS, the biological response process of endoplasmic reticulum stress (ERS) has gradually come to researchers' attention, and several studies have confirmed the involvement of ERS in the pathogenesis of PCOS and the improvement of a series of pathological manifestations of PCOS after the application of ERS inhibitors, which may be a new entry point for the treatment of PCOS. In this article, we review the relationship between ERS and various pathogenic factors of PCOS.
Get full access to this article
View all access options for this article.
References
1.
American College of Obstetricians and Gynecologists. (2018). ACOG practice bulletin No. 194: polycystic ovary syndrome. Obstet Gynecol, 131, 157–171.
2.
ArkunY., and YasemiM. (2018). Dynamics and control of the ERK signaling pathway: Sensitivity, bistability, and oscillations. PLoS One 13,0195513.
3.
AversaA., La VigneraS., RagoR., GambineriA., NappiR.E., CalogeroA.E., et al. (2020). Fundamental concepts and novel aspects of polycystic ovarian syndrome: expert consensus resolutions. Front Endocrinol (Lausanne) 11,516.
4.
AzharyJ.M.K., HaradaM., KunitomiC., KusamotoA., TakahashiN., NoseE., et al. (2020). Androgens Increase Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS. Endocrinology 161,bqaa015.
5.
AzharyJ.M.K., HaradaM., TakahashiN., NoseE., KunitomiC., KoikeH., et al. (2019). Endoplasmic Reticulum Stress Activated by Androgen Enhances Apoptosis of Granulosa Cells via Induction of Death Receptor 5 in PCOS. Endocrinology, 160, 119–132.
6.
BarryJ.A., AziziaM.M., and HardimanP.J. (2014). Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update, 20, 748–758.
7.
Behboudi-GandevaniS., Ramezani TehraniF., Rostami DovomM., FarahmandM., Bahri KhomamiM., NoroozzadehM., et al. (2016). Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecol Endocrinol, 32, 343–353.
BremerA.A., and MillerW.L. (2008). The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for Hyperandrogenism and insulin resistance. Fertil Steril, 89, 1039–1048.
10.
BrenjianS., MoiniA., YaminiN., KashaniL., FaridmojtahediM., BahramrezaieM., et al. (2020). Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers. Am J Reprod Immunol 83,e13186.
11.
BurmanA., TanjoreH., and BlackwellT.S. (2018). Endoplasmic reticulum stress in pulmonary fibrosis. Matrix Biol, 68–69, 355–365.
12.
CadaganD., KhanR., and AmerS. (2016). Thecal cell sensitivity to luteinizing hormone and insulin in polycystic ovarian syndrome. Reprod Biol, 16, 53–60.
13.
ChangH.M., ChengJ.C., LiuY., KlausenC., XuC., and LeungP.C. (2016a). Activin A-induced increase in LOX activity in human granulosa-lutein cells is mediated by CTGF. Reproduction, 152, 293–301.
14.
ChangH.M., FangY., LiuP.P., ChengJ.C., YangX., and LeungP.C. (2016b). Connective tissue growth factor mediates growth differentiation factor 8-induced increase of lysyl oxidase activity in human granulosa-lutein cells. Mol Cell Endocrinol, 434, 186–198.
15.
ChaudhariN., TalwarP., ParimisettyA., Lefebvre d'HellencourtC., and RavananP. (2014). A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress. Front Cell Neurosci 8,213.
16.
ChenL., XuW.M., and ZhangD. (2014). Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome. Fertil Steril, 102, 1167–1174.e4.
17.
CoelhoM., OliveiraT., and FernandesR. (2013). Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci, 9, 191–200.
18.
CostaE.M., SpritzerP.M., HohlA., and BachegaT.A. (2014). Effects of endocrine disruptors in the development of the female reproductive tract. Arq Bras Endocrinol Metabol, 58, 153–161.
19.
CybulskyA.V. (2017). Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases. Nat Rev Nephrol, 13, 681–696.
20.
Da BroiM.G., GiorgiV.S.I., WangF., KeefeD.L., AlbertiniD., and NavarroP.A. (2018). Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications. J Assist Reprod Genet, 35, 735–751.
21.
Dan DunnJ., AlvarezL.A., ZhangX., and SoldatiT. (2015). Reactive oxygen species and mitochondria: A nexus of cellular homeostasis. Redox Biol, 6, 472–485.
22.
Diamanti-KandarakisE., ChatzigeorgiouA., PapageorgiouE., KoundourasD., and KoutsilierisM. (2016). Advanced glycation end-products and insulin signaling in granulosa cells. Exp Biol Med (Maywood), 241, 1438–1445.
23.
Diamanti-KandarakisE., PiperiC., LivadasS., KandarakiE.A., PapageorgiouE., and KoutsilierisM. (2013). Interference of AGE-RAGE signaling with steroidogenic enzyme action in human ovarian cells; Proceedings of the Endocrine Society's 95th Annual Meeting and Expo; San Francisco, CA, USA. 15–18.
24.
Diamanti-KandarakisE., PiperiC., PatsourisE., KorkolopoulouP., PanidisD., PawelczykL., et al. (2007). Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol, 127, 581–589.
25.
DumesicD.A., AkopiansA.L., MadrigalV.K., RamirezE., MargolisD.J., SarmaM.K., et al. (2016). Hyperandrogenemia Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women. J Clin Endocrinol Metab, 101, 4178–4188.
26.
ErnstE.H., and Lykke-HartmannK. (2018). Transcripts encoding free radical scavengers in human granulosa cells from primordial and primary ovarian follicles. J Assist Reprod Genet, 35, 1787–1798.
EsserC., LawrenceB.P., SherrD.H., PerdewG.H., PugaA., BaroukiR., and CoumoulX. (2018). Old Receptor, New Tricks-The Ever-Expanding Universe of Aryl Hydrocarbon Receptor Functions. Report from the 4th AHR Meeting, 29−31 August 2018 in Paris, France. Int J Mol Sci 19,3603.
29.
FiladiR., GreottiE., and PizzoP. (2018). Highlighting the endoplasmic reticulum-mitochondria connection: Focus on Mitofusin 2. Pharmacol Res, 128, 42–51.
30.
Furat RencberS., Kurnaz OzbekS., EraldemırC., SezerZ., KumT., CeylanS., et al. (2018). Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. J Ovarian Res 11,55.
31.
GaoP., YangM., and SunL. (2018). Mitochondrial associated endoplasmic reticulum (MAM) calcium transport and regulatory proteins mediate mitochondrial calcium homeostasis. Chin J Cell Biol, 40, 585–593.
32.
GargA.D., KaczmarekA., KryskoO., VandenabeeleP., KryskoD.V., and AgostinisP. (2012). ER stress-induced inflammation: does it aid or impede disease progression?. Trends Mol Med, 18, 589–598.
33.
GhafurniyanH., AzarniaM., NabiuniM., and KarimzadehL. (2015). The effect of green tea extract on reproductive improvement in estradiol valerate-induced polycystic ovarian syndrome in rat. Iran J Pharm Res, 14, 1215–1233.
34.
GongJ., WangX.Z., WangT., ChenJ-J., XieX-Y., HuH., et al. (2017). Molecular signal networks and regulating mechanisms of the unfolded protein response. J Zhejiang Univ Sci B, 18, 1–14.
35.
GregoraszczukE.L., and PtakA. (2013). Endocrine-disrupting chemicals: some actions of POPs on female reproduction. Int J Endocrinol 2013,828532.
36.
GuarnieriT., AbruzzoP.M., and BolottaA. (2020). More than a cell biosensor: aryl hydrocarbon receptor at the intersection of physiology and inflammation. Am J Physiol Cell Physiol, 318, C1078–C1082.
37.
GuerrinaN., AloufiN., ShiF., PrasadeK., MehrotraC., TraboulsiH., et al. (2021). The aryl hydrocarbon receptor reduces LC3II expression and controls endoplasmic reticulum stress. Am J Physiol Lung Cell Mol Physiol, 320, L339–L355.
38.
Gutiérrez-RodeloC., Roura-GuibernaA., and Olivares-ReyesJ.A. (2017). Mecanismos Moleculares de la Resistencia a la Insulina: Una Actualización [Molecular Mechanisms of Insulin Resistance: An Update]. Gac Med Mex, 153, 214–228.
39.
GuzelE., ArlierS., Guzeloglu-KayisliO., TabakM.S., EkizT., SemerciN., et al. (2017). Endoplasmic Reticulum Stress and Homeostasis in Reproductive Physiology and Pathology. Int J Mol Sci 18,792.
40.
HamczykM.R., Villa-BellostaR., QuesadaV., GonzaloP., VidakS., NevadoR.M., et al. (2019). Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells. EMBO Mol Med 11,e9736.
41.
HangL., PengY., XiangR., LiX., and LiZ. (2020). Ox-LDL Causes Endothelial Cell Injury Through ASK1/NLRP3-Mediated Inflammasome Activation via Endoplasmic Reticulum Stress. Drug Des Devel Ther, 14, 731–744.
42.
Hernandez-OchoaI., Barnett-RinggoldK.R., DehlingerS.L., GuptaR.K., LeslieT.C., RobyK.F., et al. (2010). The ability of the aryl hydrocarbon receptor to regulate ovarian follicle growth and estradiol biosynthesis in mice depends on stage of sexual maturity. Biol Reprod, 83, 698–706.
43.
HuH., TianM., DingC., and YuS. (2019). The C/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Front Immunol 9,3083.
44.
IlieI.R. (2018). Advances in PCOS pathogenesis and progression-mitochondrial mutations and dysfunction. Adv Clin Chem, 86, 127–155.
45.
JeanesY.M., and ReevesS. (2017). Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Nutr Res Rev, 30, 97–105.
46.
JenaD., ChoudhuryA.K., MangarajS., SinghM., MohantyB.K., and BaliarsinhaA.K. (2018). Study of visceral and subcutaneous abdominal fat thickness and its correlation with cardiometabolic risk factors and hormonal parameters in polycystic ovary syndrome. Indian J Endocrinol Metab, 22, 321–327.
47.
JiaoP., MaJ., FengB., ZhangH., DiehlJ.A., ChinY.E., et al. (2011). FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKKβ pathways. Obesity (Silver Spring), 19, 483–491.
48.
JinJ., MaY., TongX., YangW., DaiY., PanY., et al. (2020). Metformin inhibits testosterone-induced endoplasmic reticulum stress in ovarian granulosa cells via inactivation of p38 MAPK. Hum Reprod, 35, 1145–1158.
49.
JuengelJ.L., HeathD.A., QuirkeL.D., McNattyK.P. (2006). Oestrogen receptor α and β, androgen receptor and progesterone receptor mRNA and protein localisation within the developing ovary and in small growing follicles of sheep. Reproduction, 131, 81–92.
50.
KeaneK.N., CruzatV.F., CarlessiR., de BittencourtP.I.Jr, and NewsholmeP. (2015). Molecular events linking oxidative stress and inflammation to insulin resistance and β-cell dysfunction. Oxid Med Cell Longev 2015,181643.
51.
KhadirA., KavalakattS., AbubakerJ., CherianP., MadhuD., Al-KhairiI., et al. (2016). Physical exercise alleviates ER stress in obese humans through reduction in the expression and release of GRP78 chaperone. Metabolism, 65, 1409–1420.
52.
Kuliczkowska-PłaksejJ., JończykM., Jawiarczyk-PrzybyłowskaA., StachowskaB., ZembskaA., GrzegrzółkaJ., et al. (2021). The frequency of TLR2 (rs3804099, rs3804100, and rs5743708) and TLR4 (rs4986790 and rs4986791) polymorphisms in women with polycystic ovary syndrome - preliminary study. Gynecol Endocrinol, 37, 1027–1034.
53.
KunitomiC., HaradaM., KusamotoA., AzharyJ.M., NoseE., KoikeH., et al. (2021). Induction of aryl hydrocarbon receptor in granulosa cells by endoplasmic reticulum stress contributes to pathology of polycystic ovary syndrome. Mol Hum Reprod 27,gaab003.
54.
LebeaupinC., ValléeD., HazariY., HetzC., ChevetE., and Bailly-MaitreB. (2018). Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol, 69, 927–947.
55.
LeeJ.Y., BawC., GuptaS., AzizN., and AgarwalA. (2010). Role of oxidative stress in polycystic ovary syndrome. Curr Women's Health Rev, 6, 96–107.
56.
LiW., CaoT., LuoC., CaiJ., ZhouX., XiaoX., et al. (2020). Crosstalk between ER stress, NLRP3 inflammasome, and inflammation. Appl Microbiol Biotechnol, 104, 6129–6140.
57.
LiW., FanR., XuQ., ChenJ., QuX., KuangH., et al. (2021). Mitochondrial dynamics of ovarian cells and polycystic ovary syndrome. J Int Obstet Gynecol, 48, 403–408.
58.
LimJ.J., HanC.Y., LeeD.R., and TsangB.K. (2017a). Ring finger protein 6 mediates androgen-induced granulosa cell proliferation and follicle growth via modulation of androgen receptor signaling. Endocrinology, 158, 993–1004.
59.
LimJ.J., LimaP.D.A., SalehiR., LeeD.R., and TsangB.K. (2017b). Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome. Sci Rep 7,10272.
60.
LimaP.D.A., NivetA.L., WangQ., ChenY.A., LeaderA., CheungA., et al. (2018). Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages. Biol Reprod, 99, 838–852.
61.
LiuJ., and ZhangD. (2012). [The role of oxidative stress in the pathogenesis of polycystic ovary syndrome]. Sichuan Da Xue Xue Bao Yi Xue Ban, 43, 187–190.
62.
MarkstromE., SvenssonE., ShaoR., SvanbergB., and BilligH. (2002). Survival factors regulating ovarian apoptosis-dependence on follicle differentiation. Reproduction, 123, 23–30.
63.
MasjediF., KeshtgarS., AgahF., and KarbalaeiN. (2019). Association Between Sex Steroids and Oxidative Status with Vitamin D Levels in Follicular Fluid of Non-obese PCOS and Healthy Women. J Reprod Infertil, 20, 132–142.
64.
MatsudaF., InoueN., ManabeN., and OhkuraS. (2012). Follicular growth and atresia in mammalian ovaries: regulation by survival and death of granulosa cells. J Reprod Dev, 58, 44–50.
65.
McNeillyA.S., and DuncanW.C. (2013). Rodent models of polycystic ovary syndrome. Mol Cell Endocrinol, 373, 2–7.
66.
MerhiZ., BuyukE., and CipollaM.J. (2018). Advanced glycation end products alter steroidogenic gene expression by granulosa cells: an effect partially reversible by vitamin D. Mol Hum Reprod, 24, 318–326.
67.
MikaeiliS., RashidiB.H., SafaM., NajafiA., SobhaniA., AsadiE., et al. (2016). Altered FoxO3 expression and apoptosis in granulosa cells of women with polycystic ovary syndrome. Arch Gynecol Obstet, 294, 185–192.
68.
MunirI., YenH.W., GellerD.H., TorbatiD., BierdenR.M., WeitsmanS.R., et al. (2004). Insulin augmentation of 17alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells. Endocrinology, 145, 175–183.
69.
NewsholmeP., RebelatoE., AbdulkaderF., KrauseM., CarpinelliA., and CuriR. (2012). Reactive oxygen and nitrogen species generation, antioxidant defenses, and β-cell function: a critical role for amino acids. J Endocrinol, 214, 11–20.
70.
NiL., YuanC., and WuX. (2021). Endoplasmic reticulum stress in diabetic nephrology: regulation, pathological role, and therapeutic potential. Oxid Med Cell Longev 2021,7277966.
71.
OzcanU., OzcanL., YilmazE., DüvelK., SahinM., ManningB.D., et al. (2008). Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell, 29, 541–551.
72.
PaliouraE., and Diamanti-KandarakisE. (2015). Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs). Rev Endocr Metab Disord, 16, 365–371.
73.
PapalouO., M VictorV., and Diamanti-KandarakisE. (2016). Oxidative stress in polycystic ovary syndrome. Curr Pharm Design, 22, 2709–2722.
74.
PerezG.I., TrbovichA.M., GosdenR.G., and TillyJ.L. (2000). Mitochondria and the death of oocytes. Nature, 403, 500–501.
75.
PetersenM.C., and ShulmanG.I. (2018). Mechanisms of insulin action and insulin resistance. Physiol Rev, 98, 2133–2223.
76.
PiperiC., AdamopoulosC., DalagiorgouG., Diamanti-KandarakisE., and PapavassiliouA.G. (2012). Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. J Clin Endocrinol Metab, 97, 2231–2242.
77.
PopovicM., SartoriusG., and Christ-CrainM. (2019). Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?. Semin Immunopathol, 41, 447–459.
78.
QiaoJ., QiX., XuY., and PangY. (2020). Pay attention to polycystic ovary syndrome, an important reproductive endocrine disease affecting women's health. Chin J Pract Gynecol Obstet, 36, 1–9.
79.
ReganS.L.P., KnightP.G., YovichJ.L., StangerJ.D., LeungY., ArfusoF., et al. (2018). The effect of ovarian reserve and receptor signalling on granulosa cell apoptosis during human follicle development. Mol Cell Endocrinol, 470, 219–227.
80.
RochaM., Diaz-MoralesN., Rovira-LlopisS., Escribano-LopezI., BañulsC., Hernandez-MijaresA., et al. (2016). Mitochondrial dysfunction and endoplasmic reticulum stress in diabetes. Curr Pharm Des, 22, 2640–2649.
81.
RojasI.Y., MoyerB.J., RingelbergC.S., and TomlinsonC.R. (2020). Reversal of obesity and liver steatosis in mice via inhibition of aryl hydrocarbon receptor and altered gene expression of CYP1B1, PPARα, SCD1, and osteopontin. Int J Obes (Lond), 44, 948–963.
82.
RostamtabarM., EsmaeilzadehS., TouraniM., RahmaniA., BaeeM., ShirafkanF., et al. (2021). Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome. J Cell Physiol, 236, 824–838.
83.
SchwarzD.S., and BlowerM.D. (2015). The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol Life Sci, 73, 79–94.
84.
SirardM.A. (2019). Distribution and dynamics of mitochondrial DNA methylation in oocytes, embryos and granulosa cells. Sci Rep 9,11937.
85.
SitiH.N., KamisahY., and KamsiahJ. (2015). The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vascul Pharmacol, 71, 40–56.
86.
SniderA.P., and WoodJ.R. (2019). Obesity induces ovarian inflammation and reduces oocyte quality. Reproduction, 158, R79–R90.
87.
SongX., ShenQ., FanL., YuQ., JiaX., SunY., et al. (2018). Dehydroepiandrosterone-induced activation of mTORC1 and inhibition of autophagy contribute to skeletal muscle insulin resistance in a mouse model of polycystic ovary syndrome. Oncotarget, 9, 11905–11921.
88.
SpritzerP.M., LeckeS.B., SatlerF., and MorschD.M. (2015). Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction, 149, R219–R227.
89.
SunY., ZhangD., LiuX., LiX., LiuF., YuY., et al. (2018). Endoplasmic Reticulum Stress Affects Lipid Metabolism in Atherosclerosis Via CHOP Activation and Over-Expression of miR-33. Cell Physiol Biochem, 48, 1995–2010.
90.
SuzukiT., GaoJ., IshigakiY., KondoK., SawadaS., IzumiT., et al. (2017). ER Stress protein CHOP mediates insulin resistance by modulating adipose tissue macrophage polarity. Cell Rep, 18, 2045–2057.
91.
TakahashiN., HaradaM., AzharyJ.M.K., KunitomiC., NoseE., TeraoH., et al. (2019). Accumulation of advanced glycation end products in follicles is associated with poor oocyte developmental competence. Mol Hum Reprod, 25, 684–694.
92.
TakahashiN., HaradaM., HirotaY., NoseE., AzharyJ.M., KoikeH., et al. (2017). Activation of endoplasmic reticulum stress in granulosa cells from patients with polycystic ovary syndrome contributes to ovarian fibrosis. Sci Rep 7,10824.
93.
TatoneC., and AmicarelliF. (2013). The aging ovary—the poor granulosa cells. Fertil Steril, 99, 12–17.
94.
TeinoI., MatvereA., KuuseS., IngerpuuS., MaimetsT., KristjuhanA., et al. (2014). Transcriptional repression of the Ahr gene by LHCGR signaling in preovulatory granulosa cells is controlled by chromatin accessibility. Mol Cell Endocrinol, 382, 292–301.
95.
UnokiH., and YamagishiS. (2008). Advanced glycation end products and insulin resistance. Curr Pharm Des, 14, 987–989.
96.
UribarriJ., CaiW., SanduO., PeppaM., GoldbergT., and VlassaraH. (2005). Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci, 1043, 461–466.
97.
UrraH., DufeyE., AvrilT., ChevetE., and HetzC. (2016). Endoplasmic reticulum stress and the hallmarks of cancer. Trends Cancer, 2, 252–262.
98.
UrraH., DufeyE., LisbonaF., Rojas-RiveraD., and HetzC. (2013). When ER stress reaches a dead end. Biochim Biophys Acta, 1833, 3507–3517.
99.
VictorV.M., Rovira-LlopisS., BañulsC., Diaz-MoralesN., Martinez de MarañonA., Rios-NavarroC., et al. (2016). Insulin resistance in PCOS patients enhances oxidative stress and leukocyte adhesion: role of myeloperoxidase. PLoS One 11,e0151960.
100.
WalterP., and RonD. (2011). The unfolded protein response: from stress pathway to homeostatic regulation. Science, 334, 1081–1086.
101.
WanY., YangL., JiangS., QianD., and DuanJ. (2021). Excessive apoptosis in ulcerative colitis: crosstalk between apoptosis, ROS, ER stress, and intestinal homeostasis. Inflamm Bowel Dis [Epub ahead of print]; DOI: 10.1093/ibd/izab277.
102.
WangC.L., FanY., Chun-HsienT., ChiuC.H., TsaiH.J., and ChouC.H. (2014). Salmonella Enteritidis infection slows steroidogenesis and impedes cell growth in hen granulosa cells. Avian Dis, 58, 511–517.
103.
WangF., FanL.H., LiA., DongF., HouY., SchattenH., et al. (2021). Effects of various calcium transporters on mitochondrial Ca2+ changes and oocyte maturation. J Cell Physiol, 236, 6548–6558.
104.
WuL., GuoT., DengR., LiuL., and YuY. (2021). Apigenin Ameliorates Insulin Resistance and Lipid Accumulation by Endoplasmic Reticulum Stress and SREBP-1c/SREBP-2 Pathway in Palmitate-Induced HepG2 Cells and High-Fat Diet-Fed Mice. J Pharmacol Exp Ther, 377, 146–156.
105.
WuY., BaumgartenS.C., ZhouP., and StoccoC. (2013). Testosterone-dependent interaction between androgen receptor and aryl hydrocarbon receptor induces liver receptor homolog 1 expression in rat granulosa cells. Mol Cell Biol, 33, 2817–2828.
106.
XiaS.W., WangZ.M., SunS.M., SuY., LiZ.H., ShaoJ.J., et al. (2020). Endoplasmic reticulum stress and protein degradation in chronic liver disease. Pharmacol Res 161,105218.
107.
XiaX., JiangH., MaC., ShuL., LiH., and GuS. (2015). Effect of androgenic therapy on apoptosis of cumulus granulosa cells in patients with polycystic ovary syndrome. Guangdong Med J, 36, 241–244.
108.
XuQ., ChenC., LinA., and XieY. (2017). Endoplasmic reticulum stress-mediated membrane expression of CRT/ERp57 induces immunogenic apoptosis in drug-resistant endometrial cancer cells. Oncotarget, 8, 58754–58764.
109.
YangL., ZhangZ., ZhuoY., CuiL., LiC., LiD., et al. (2018). Resveratrol alleviates sepsis-induced acute lung injury by suppressing inflammation and apoptosis of alveolar macrophage cells. Am J Transl Res, 10, 1961–1975.
110.
YangQ., ZhaoY., QiuX., ZhangC., LiR., and QiaoJ. (2015). Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study. Hum Reprod, 30, 1964–1973.
111.
YangY., QiaoJ., LiR., and LiM.Z. (2011). Is interleukin-18 associated with polycystic ovary syndrome?. Reprod Biol Endocrinol 9,7.
112.
YangY., ZhouQ., GaoA., ChenL., and LiL. (2020). Endoplasmic reticulum stress and focused drug discovery in cardiovascular disease. Clin Chim Acta, 504, 125–137.
113.
YaribeygiH., FarrokhiF.R., ButlerA.E., and SahebkarA. (2019). Insulin resistance: Review of the underlying molecular mechanisms. J Cell Physiol, 234, 8152–8161.
114.
YeW., XieT., SongY., and ZhouL. (2021). The role of androgen and its related signals in PCOS. J Cell Mol Med, 25, 1825–1837.
115.
ZhangJ., BaoY., ZhouX., and ZhengL. (2019). Polycystic ovary syndrome and mitochondrial dysfunction. Reprod Biol Endocrinol 17,67.
116.
ZhangY., RanY., KongL., GengL., HuangH., ZhangH., et al. (2021). Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism. J Ovarian Res 14,97.
117.
ZhangY., SunX., SunX., MengF., HuM., LiX., et al. (2016). Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus. Sci Rep 6,30679.
118.
ZhouJ., TanY., WangX., and ZhuM. (2021). Paeoniflorin attenuates DHEA-induced polycystic ovary syndrome via inactivation of TGF-β1/Smads signaling pathway in vivo. Aging (Albany NY), 13, 7084–7095.
119.
ZhuB., ChenY., XuF., ShenX., ChenX., LvJ., et al. (2021). Androgens impair β-cell function in a mouse model of polycystic ovary syndrome by activating endoplasmic reticulum stress. Endocr Connect, 10, 265–272.
120.
ZuoT., ZhuM., and XuW. (2016). Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev 2016,8589318.
